Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
Loading...
Date
2022-09-03
Authors
Bongomin, Felix
Kwizera, Richard
Mande, Emmanuel
Aloyo, Sharley Melissa
Achan, Beatrice
Namusobya, Martha
Sereke, Senai Goitom
Batte, Charles
Kiguli, Sarah
Baruch Baluku, Joseph
Journal Title
Journal ISSN
Volume Title
Publisher
African Health Sciences
Abstract
Invasive pulmonary aspergillosis is known to complicate the coronavirus diseases-2019 (COVID-19), especially those with crit ical illness. We investigated the baseline anti-Aspergillus antibody serostatus of patients with moderate-critical COVID-19 hos pitalized at 3 COVID-19 Treatment Units in Uganda. All 46 tested patients, mean age 30, and 11% with underlying respiratory
disease had a negative serum anti-Aspergillus IgM/IgG antibody immunochromatographic test on day 3 (mean) of symptom
onset (range 1-26), but follow up specimens to assess seroconversion were not available.
Description
Keywords
Invasive pulmonary aspergillosis,, COVID-19,, critical illness,, Uganda
Citation
Bongomin, F., Kwizera, R., Mande, E., Aloyo, S. M., Achan, B., Namusobya, M., ... & Kirenga, B. J. (2022). Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda. African Health Sciences, 22(3), 506-511.